Mutation-Directed Therapeutics for Neurofibromatosis Type I

Significant advances in biotechnology have led to the development of a number of different mutation-directed therapies. Some of these techniques have matured to a level that has allowed testing in clinical trials, but few have made it to approval by drug-regulatory bodies for the treatment of specif...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Andre Leier (Autor), David M. Bedwell (Autor), Ann T. Chen (Autor), George Dickson (Autor), Kim M. Keeling (Autor), Robert A. Kesterson (Autor), Bruce R. Korf (Autor), Tatiana T. Marquez Lago (Autor), Ulrich F. Müller (Autor), Linda Popplewell (Autor), Jiangbing Zhou (Autor), Deeann Wallis (Autor)
Format: Knjiga
Izdano: Elsevier, 2020-06-01T00:00:00Z.
Teme:
Online pristup:Connect to this object online.
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Internet

Connect to this object online.

3rd Floor Main Library

Detalji primjeraka od 3rd Floor Main Library
Signatura: A1234.567
Primjerak 1 Dostupno